Xeris Pharmaceuticals | XERS - PE Price to Earnings


Xeris Pharmaceuticals reported 76.05 in PE Price to Earnings for its fiscal quarter ending in March of 2026.





Pe Change Date
Celltrion 58.97 8.86 Mar/2026
Cspc Pharmaceutical 23.62 0.78 Mar/2026
Deva Holding AS 6.55 2.01 Sep/2023
Dianthus Therapeutics 3.8 1.53 Sep/2024
Divis Laboratories Ltd 58.35 1.4 Jun/2026
Eli Lilly 32.9 7.37 Jun/2026
Kangmei Pharma 1.11K 2.04K Mar/2026
Knight Therapeutics 257.34 166.24 Dec/2025
Laboratorios Farma 18.78 6.64 Dec/2023
Malin Corporation 11.81 0.72 Jun/2023
Neuren Pharmaceuticals 72.14 59.86 Dec/2025
Organigram Holdings 12.01 222.99 Mar/2026
Ovoca Bio 1.83 3.29 Jun/2024
Pacira 35.68 2.9 Jun/2026
Perrigo 27.45 31.51 Mar/2026
Pharma Mar 16.35 2.78 Jun/2026
Qiagen NV 16.72 2.76 Jun/2026
Sartorius 52.99 9.56 Jun/2026
Sino Biopharmaceutical 17.03 0.89 Jun/2025
Supernus Pharmaceuticals 65.37 21.16 Jun/2026
Tilray 11.56 80.19 Sep/2025
Zealand Pharma A/S 3.27 1.86 Mar/2026
Zz Pientze Pharmaceu 47.68 1.35 Mar/2026